- Adherence
- Children
- Clinical reviews
- Drug supply
- Guidelines
- Hepatitis and HIV coinfection
- HIV Testing
- Infant feeding
- Laboratory monitoring
- Malaria & HIV
- Neurological problems, including HIV dementia
- Nutrition
- Palliative care
- Prevention
- Prevention of mother-to child transmission
- Scaling up treatment and models of service delivery
- Side-effects
- South Africa
- Starting treatment
- Stigma
- Treatment failure
- Tuberculosis
- Improving HIV diagnosis in TB patients: new approaches bearing fruit (24/7/08)
- Getting the formula right to deliver HIV services, including ART, to TB patients with HIV (24/7/08)
- Three I's to reduce the burden of TB in people with HIV (26/6/08)
- Recommendations on Three I's implementation (26/6/08)
- Our health facilities are still unsafe: why we all need to do something about TB infection control (29/5/08)
- Expert views on TB infection control measures (29/5/08)
- Intensified case finding: developing an action plan - 12/3/2008
- Think TB in people with HIV: start routinely screening for TB now - 12/3/2008
- Treating MDR TB in the community: what are the challenges? (17/1/08)
- Isoniazid preventive therapy for TB in people with HIV: barriers to national implementation - 29/11/2007
- Time for clear and simple messages about delivering isoniazid preventive therapy (IPT) - 30/11/2007
- Failure to suppress viral load more likely with nevirapine than efavirenz if ART started during TB treatment - 30/11/2007
- It’s time to integrate TB/HIV care on a national scale - 17/7/2007
- TB transmission in healthcare settings and improving infection control - 19/12/2006
- Scaling up laboratory capacity for the coming storm of XDR-TB, and why the HIV treating community must get involved now - 28/11/2006
- Expanding beyond DOTS to stop TB - 31/3/2006
- Improving the diagnosis of active TB in people with HIV - 19/3/2006
- Isoniazid preventative therapy - 19/3/2006
- HIV/AIDS treatment activists welcomed at World Tuberculosis (TB) Meeting but is the TB world ready for everything they have to say? - 19/3/2006
- HIV's impact on TB control: is it time to re-think TB control strategies? - 27/10/2005
- An Integrated Approach to HIV and TB Care in Adults in Resource-Limited Settings - Part 1 - 27/10/2005
- Isoniazid prophylaxis treatment for children with HIV: is it ready for implementation? - 27/10/2005
- Treating latent TB - 27/10/2005
- Viral load testing
Tuberculosis
Improving HIV diagnosis in TB patients: new approaches bearing fruit (24/7/08)
Getting the formula right to deliver HIV services, including ART, to TB patients with HIV (24/7/08)
Three I's to reduce the burden of TB in people with HIV (26/6/08)
Recommendations on Three I's implementation (26/6/08)
Our health facilities are still unsafe: why we all need to do something about TB infection control (29/5/08)
Expert views on TB infection control measures (29/5/08)
Intensified case finding: developing an action plan - 12/3/2008
Think TB in people with HIV: start routinely screening for TB now - 12/3/2008
Treating MDR TB in the community: what are the challenges? (17/1/08)
Isoniazid preventive therapy for TB in people with HIV: barriers to national implementation - 29/11/2007
Time for clear and simple messages about delivering isoniazid preventive therapy (IPT) - 30/11/2007
Failure to suppress viral load more likely with nevirapine than efavirenz if ART started during TB treatment - 30/11/2007
It’s time to integrate TB/HIV care on a national scale - 17/7/2007
TB transmission in healthcare settings and improving infection control - 19/12/2006
Scaling up laboratory capacity for the coming storm of XDR-TB, and why the HIV treating community must get involved now - 28/11/2006
Expanding beyond DOTS to stop TB - 31/3/2006
Improving the diagnosis of active TB in people with HIV - 19/3/2006
Isoniazid preventative therapy - 19/3/2006
HIV/AIDS treatment activists welcomed at World Tuberculosis (TB) Meeting but is the TB world ready for everything they have to say? - 19/3/2006
HIV's impact on TB control: is it time to re-think TB control strategies? - 27/10/2005
An Integrated Approach to HIV and TB Care in Adults in Resource-Limited Settings - Part 1 - 27/10/2005
Isoniazid prophylaxis treatment for children with HIV: is it ready for implementation? - 27/10/2005
Treating latent TB - 27/10/2005
About HATIP
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.
Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.
Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.
latest aidsmap news
- Microbicide and PrEP potential for anal sex explored further in monkey studies
- ‘Shocking’ rates of adverse events seen with traditional and medical circumcision in Kenya
- Brazil rejects tenofovir patent
- Fibrosis linked to rapid loss of gut CD4 cells after HIV infection
- Poor results using non-medical HIV counsellors to screen for treatment eligibility in Malawi
- Raltegravir may cause temporary worsening of pre-existing depression
- Etravirine (<i>Intelence</i>) approved in Europe for treatment-experienced patients
- Belief in conspiracy theories means less HIV testing in South Africa
- Case report - viral load undetectable in blood, but detectable in semen
- Blood viral load predicts HIV transmission better than semen viral load in small study among MSM